Bessemer Group Inc Biomarin Pharmaceutical Inc Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bessemer Group Inc holds 5,020 shares of BMRN stock, worth $337,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,020

Previous 5,215 3.74%

Holding current value

$337,293

Previous $429,000 17.72%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$69.02 - $93.84 $13,458 - $18,298	-195 Reduced 3.74%	5,020 $353,000
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $8,155 - $10,540	-107 Reduced 2.01%	5,215 $503,000
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $9,102 - $10,109	107 Added 2.05%	5,322 $471,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $31,967 - $42,908	-395 Reduced 7.04%	5,215 $540,000
Q3 2022 Nov 09, 2022	BUY	$82.16 - $96.94 $460,917 - $543,833	5,610 New	5,610 $476,000
Q2 2022 Aug 10, 2022	SELL	$71.48 - $86.85 $28,091 - $34,132	-393 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$71.72 - $91.47 $12,048 - $15,366	-168 Reduced 29.95%	393 $35,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $5,682 - $6,495	-76 Reduced 11.93%	561 $43,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $44,838 - $54,414	600 Added 1621.62%	637 $48,000
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $2,943 - $4,596	37 New	37 $5,000
Q4 2019 Feb 04, 2020	SELL	$64.27 - $86.37 $20.2 Million - $27.1 Million	-314,132 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$67.4 - $85.11 $1.47 Million - $1.86 Million	-21,868 Reduced 6.51%	314,132 $21.2 Million
Q2 2019 Jul 19, 2019	BUY	$80.35 - $93.9 $27 Million - $31.5 Million	335,874 Added 266566.66%	336,000 $28.8 Million
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $6,567 - $7,692	78 Added 162.5%	126 $11,000
Q4 2018 Feb 12, 2019	BUY	$80.14 - $106.07 $3,846 - $5,091	48 New	48 $4,000
Q1 2018 May 10, 2018	SELL	$77.67 - $92.63 $27,184 - $32,420	-350 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$80.6 - $94.95 $28,209 - $33,232	350	350 $33,000

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Biomarin Pharmaceutical Inc Transaction History